Benchmark analyst Bill Sutherland maintains Select Medical Hldgs (NYSE:SEM) with a Buy and raises the price target from $42 to $48.
Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.